Ken Griffin’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,581
| Closed | -$6.7K | – | 6288 |
|
|
2025
Q1 | $6.7K | Buy |
+15,581
| New | +$6.7K | ﹤0.01% | 5717 |
|
|
2024
Q4 | – | Sell |
-586
| Closed | -$19.6K | – | 6308 |
|
|
2024
Q3 | $19.6K | Buy |
+586
| New | +$19.6K | ﹤0.01% | 5339 |
|
|
2023
Q2 | – | Sell |
-2
| Closed | -$1.28K | – | 6072 |
|
|
2023
Q1 | $1.28K | Sell |
2
-2
| -50% | -$1.28K | ﹤0.01% | 5746 |
|
|
2022
Q4 | $1.29K | Sell |
4
-18
| -82% | -$5.79K | ﹤0.01% | 5904 |
|
|
2022
Q3 | $11K | Buy |
+22
| New | +$11K | ﹤0.01% | 5630 |
|
|
2022
Q2 | – | Sell |
-12
| Closed | -$16K | – | 6386 |
|
|
2022
Q1 | $16K | Sell |
12
-24
| -67% | -$32K | ﹤0.01% | 6164 |
|
|
2021
Q4 | $41K | Buy |
36
+10
| +38% | +$11.4K | ﹤0.01% | 6206 |
|
|
2021
Q3 | $40K | Sell |
26
-32
| -55% | -$49.2K | ﹤0.01% | 6173 |
|
|
2021
Q2 | $114K | Buy |
58
+31
| +115% | +$60.9K | ﹤0.01% | 5899 |
|
|
2021
Q1 | $50K | Buy |
27
+16
| +145% | +$29.6K | ﹤0.01% | 6100 |
|
|
2020
Q4 | $24K | Sell |
11
-9
| -45% | -$19.6K | ﹤0.01% | 4961 |
|
|
2020
Q3 | $63K | Buy |
+20
| New | +$63K | ﹤0.01% | 4350 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$27K | – | 4754 |
|
|
2018
Q4 | $27K | Buy |
+1
| New | +$27K | ﹤0.01% | 4200 |
|
|
2018
Q2 | – | Hold |
0
| – | -$31K | – | 4339 |
|
|
2018
Q1 | – | Hold |
0
| – | -$52K | – | 3815 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3618 |
|
|
2017
Q2 | – | Hold |
0
| – | -$46K | – | 3851 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3412 |
|